ResMed Inc. RMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 418.41M | 383.43M | 398.73M | 392.59M | 348.54M |
| Total Depreciation and Amortization | 51.83M | 48.83M | 62.60M | 55.94M | 51.27M |
| Total Amortization of Deferred Charges | -- | 6.29M | 6.43M | 6.39M | 6.40M |
| Total Other Non-Cash Items | -33.67M | 24.45M | 35.20M | 27.12M | 25.86M |
| Change in Net Operating Assets | -14.15M | -8.37M | 51.16M | -142.30M | 25.26M |
| Cash from Operations | 422.42M | 454.63M | 554.13M | 339.75M | 457.32M |
| Capital Expenditure | -48.74M | -51.13M | -33.65M | -28.54M | -42.97M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -7.49M | -325.32M | -24.88M | 0.00 | -522.00K |
| Divestitures | 450.82M | -- | -- | -- | -- |
| Other Investing Activities | -2.54M | -7.21M | 509.00K | -22.40M | -9.09M |
| Cash from Investing | 392.06M | -383.65M | -58.03M | -50.94M | -52.58M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -250.00M | -5.00M | 0.00 | -5.00M | -- |
| Issuance of Common Stock | 3.65M | 29.31M | 7.43M | 29.56M | 8.21M |
| Repurchase of Common Stock | -936.70M | -200.39M | -175.43M | -195.32M | -150.73M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -94.95M | -87.09M | -87.24M | -87.58M | -87.75M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.28B | -263.16M | -255.24M | -258.35M | -230.27M |
| Foreign Exchange rate Adjustments | 5.03M | 905.00K | 2.58M | 2.77M | -71.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -458.49M | -191.28M | 243.44M | 33.22M | 174.40M |